Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

10/06/2020, Tuesday

Media Contacts:
Kristy Marks
kristy.marks@bausch.com
(908) 927-0683

Nathan Molinari
Nathan.molinari@zenogroup.com
(917) 325-7463

BAUSCH + LOMB ANNOUNCES NEW SCIENTIFIC AND CLINICAL ANALYSES TO BE PRESENTED ON BAUSCH + LOMB INFUSE SILICONE HYDROGEL DAILY DISPOSABLE CONTACT LENSES DURING THE AMERICAN ACADEMY OF OPTOMETRY ANNUAL MEETING

 

 


BRIDGEWATER, N.J., Oct. 6, 2020 – Bausch + Lomb, a leading global eye health business, today announced that three poster presentations will feature the company’s new silicone hydrogel (SiHy) daily disposable contact lens, Bausch + Lomb INFUSE, during the virtual American Academy of Optometry (AAO) Annual Meeting (Oct. 7-22, 2020).

 

 

“Over the past two decades, we have seen many innovations in contact lens materials aimed at addressing contact lens comfort and vision. However, it was seeking to better understand ocular surface homeostasis that has allowed us to deliver a next generation silicone hydrogel material with our breakthrough ProBalance Technology, which is a proprietary combination of ingredients inspired by the TFOS (Tear Film and Ocular Surface Society) DEWS II (Dry Eye Workshop) report,” said John Ferris, general manager, U.S. Vision Care, Bausch + Lomb. “It is through research and analyses like those we look forward to presenting at AAO this year that have made it possible for us to bring forward this innovative contact lens, providing patient’s exceptional satisfaction by helping to minimize their symptoms of contact lens dryness.”

The poster presentations will be accessible to conference attendees via the AAO website from Oct. 7-22, 2020. On Oct. 9, 2020, from 4:00-6:00 p.m. ET, the authors will present their posters in the virtual AAO presentation room.

The complete list of poster presentations on Bausch + Lomb INFUSE contact lenses is as follows:

  • Reindel, William. “Assessment of a Novel Silicone Hydrogel Daily Disposable Lens among Subjects with Contact Lens Related Dryness.”
    • A clinical evaluation of comfort and vision experiences of subjects with and without contact lens related dryness while wearing a novel daily disposable silicone hydrogel lens containing moisturizers and osmoprotectants.
  • Schafer, Jeffrey. “A Clinical Assessment of Dehydration Resistance for a Novel Silicone Hydrogel Lens and Six Silicone Hydrogel Daily Disposable Lenses.”
    • An assessment of the dehydration resistance of a novel kalifilcon A silicone hydrogel lens compared to six daily disposable silicone hydrogel lenses after 16 hours of wear.
  • VanDerMeid, Karl. “Evaluation of Erythritol and Glycerin Osmoprotection Characteristics on an Ocular Surface Cell Line under Hyperosmotic Conditions.”
    • An evaluation to determine if a combination of erythritol and glycerin can help maintain balance of transformed human corneal epithelial cells (THCEpiC) subjected to hyperosmotic conditions in-vitro.

About Bausch + Lomb INFUSE Contact Lenses
Bausch + Lomb INFUSE contact lenses are the only SiHy daily disposable with a next generation material infused with ProBalance Technology that work together to help maintain ocular surface homeostasis to help minimize symptoms of contact lens dryness and discomfort for exceptional clarity and comfort. Approximately a third of the 45 million lens wears in the United States experience these symptoms.2,3 The ProBalance Technology formula is infused into the lens material during the manufacturing process. These proprietary ingredients are released during lens wear. Bausch + Lomb INFUSE combines exceptional breathability for healthy lens wear with high moisture content and a low modulus. It also maintains 96% of its moisture for a full 16 hours. For more information on Bausch + Lomb INFUSE contact lenses, visit www.BauschInfuse.com/ECP.

 

About Bausch + Lomb
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in approximately more than 100 countries. For more information, visit www.bausch.com.

References:

  1. Multi-Sponsor Surveys Inc. The 2019 Study of the U.S. Consumer Contact Lens Market. January 2020.
  2. American Optometric Association. www.aoa.org.
  3. Centers for Disease Control and Prevention. www.cdc.gov.
 

###

 

Bausch + Lomb INFUSE and ProBalance Technology are a trademarks of Bausch & Lomb Incorporated or its affiliates.
© 2020 Bausch & Lomb Incorporated or its affiliates.
INF.0231.USA.20

Print

Number of views (1539)/Comments (0)

x